Nanosonics Continues On-Market Buy-Back With Daily Share Repurchases

Nanosonics Limited ( (AU:NAN) ) has shared an announcement.

Nanosonics Limited, an ASX-listed medical technology company specialising in infection prevention products for healthcare markets, trades under the ticker NAN with ordinary fully paid shares as its main equity instrument. The company targets hospitals and clinical facilities that require high standards of disinfection and sterilisation in their operations.

The company issued a daily update on its ongoing on-market share buy-back program, confirming that a total of 4,807,341 shares had been repurchased prior to the latest reporting date. In the most recent trading day covered by the notice, Nanosonics bought back an additional 100,000 ordinary fully paid shares, signalling continued capital management activity that may support earnings per share and adjust the company’s capital structure over time.

The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.55 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.

More about Nanosonics Limited

Nanosonics Limited is a listed company on the ASX under the code NAN, with ordinary fully paid shares as its primary security class. The business operates within the medical technology sector, focusing on infection prevention solutions for healthcare settings and related clinical environments.

Average Trading Volume: 796,047

Technical Sentiment Signal: Sell

Current Market Cap: A$1.08B

Learn more about NAN stock on TipRanks’ Stock Analysis page.